Index by author

June 2022; Volume 42,Issue 6

  1. Aanes, SIV GYDA

    1. Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer
      CARSTEN NIEDER, SIV GYDA AANES and ELLINOR C. HAUKLAND
      Anticancer Research June 2022, 42 (6) 3061-3066; DOI: https://doi.org/10.21873/anticanres.15793

  2. Abbona, ANDREA

    1. Effect of Eribulin on Angiogenesis and the Expression of Endothelial Adhesion Molecules
      ANDREA ABBONA, MATTEO PACCAGNELLA, SIMONETTA ASTIGIANO, STEFANIA MARTINI, NERINA DENARO, FIORELLA RUATTA, OTTAVIA BARBIERI, MARCO MERLANO and ORNELLA GARRONE
      Anticancer Research June 2022, 42 (6) 2859-2867; DOI: https://doi.org/10.21873/anticanres.15767

  3. Adachi, TOMOHIKO

    1. Prognostic Impact of Relative Dose Intensity of Adjuvant Chemotherapy With S-1 on Pancreatic Ductal Adenocarcinoma
      HAJIME MATSUSHIMA, TOMOHIKO ADACHI, MASAAKI HIDAKA, MAMPEI YAMASHITA, TAKASHI HAMADA, SAEKO FUKUI, TAKAYUKI TANAKA, HAJIME IMAMURA, KYOHEI YOSHINO, TOTA KUGIYAMA, AMANE KITASATO, TAKANOBU HARA, AKIHIKO SOYAMA, KAZUMA KOBAYASHI, YORIHISA SUMIDA, TAMOTSU KUROKI and SUSUMU EGUCHI
      Anticancer Research June 2022, 42 (6) 3133-3141; DOI: https://doi.org/10.21873/anticanres.15802
    2. Open Access
      The Outcome of Conversion Liver Resection Surgery by Lenvatinib Treatment: A Single Center Experience
      MASAAKI HIDAKA, TAKANOBU HARA, AKIHIKO SOYAMA, RYU SASAKI, HAJIME MATSUSHIMA, TAKAYUKI TANAKA, TAKASHI HAMADA, HAJIME IMAMURA, TOMOHIKO ADACHI, KENGO KANETAKA, HISAMITSU MIYAAKI, SHINJI OKANO and SUSUMU EGUCHI
      Anticancer Research June 2022, 42 (6) 3049-3054; DOI: https://doi.org/10.21873/anticanres.15791

  4. Ahmadi, NIMA

    1. Open Access
      Cytoreductive Surgery and HIPEC for Malignant Peritoneal Mesothelioma: Outcomes and Survival From an Australian Centre
      RAPHAEL SHAMAVONIAN, ERNEST CHENG, JOSH B. KARPES, SHOMA BARAT, NIMA AHMADI and DAVID L. MORRIS
      Anticancer Research June 2022, 42 (6) 2939-2944; DOI: https://doi.org/10.21873/anticanres.15776

  5. Akahoshi, SHINICHI

    1. Successful Treatment of Intrahepatic Cholangiocarcinoma With Liver/Lung Metastasis and Peritoneal Dissemination After Liver Resection
      KAZUKI MATSUMURA, KENSUKE YAMAMURA, ERI ODA, SHINICHI AKAHOSHI, TAKATOSHI ISHIKO, TATSUNORI MIYATA, HIDEAKI MIYAMOTO, TOSHIHIKO MOTOHARA, AKIRA SASAO, YOSHIHIRO KOMOHARA, HIDECHIKA KAWANO and TORU BEPPU
      Anticancer Research June 2022, 42 (6) 3209-3215; DOI: https://doi.org/10.21873/anticanres.15811

  6. Akin, IBRAHIM

    1. Adverse Cardiovascular Effects of Anti-tumor Therapies in Patients With Breast Cancer: A Single-center Cross-sectional Analysis
      STEPHANIE ROSENKAIMER, TINA SIEBURG, LAURA WINTER, ATHANASIOS MAVRATZAS, WOLF-KARSTEN HOFMANN, RALF-DIETER HOFHEINZ, IBRAHIM AKIN, DANIEL DUERSCHMIED and ANNA HOHNECK
      Anticancer Research June 2022, 42 (6) 3075-3084; DOI: https://doi.org/10.21873/anticanres.15795

  7. Amico, PAOLO

    1. Contralateral Interhemispheric Transfalcine Approach for Supratentorial Extraventricular Ependymoma Resection
      MATIAS BALDONCINI, GIANLUCA FERINI, GIUSEPPE E. UMANA, BIPIN CHAURASIA, MICKAELA ECHAVARRIA DEMICHELIS, JUAN F. VILLALONGA, PAOLO PALMISCIANO, PAOLO AMICO, SABINO LUZZI, DEREK O. PIPOLO and ALVARO CAMPERO
      Anticancer Research June 2022, 42 (6) 3203-3207; DOI: https://doi.org/10.21873/anticanres.15810

  8. An, JI YEONG

    1. Feasibility of Gastric Tumor Xenograft (GTX)-derived Cell Lines for Individualized Anti-cancer Drug Screening
      SUNG EUN OH, MI YUN OH, SU MI KIM, SUN YOUNG KIM, JI YEONG AN, JUN HO LEE, TAE SUNG SOHN, JAE MOON BAE and MIN-GEW CHOI
      Anticancer Research June 2022, 42 (6) 2883-2891; DOI: https://doi.org/10.21873/anticanres.15770

  9. Aoki, YOICHI

    1. Effects of Pegylated Liposomal Doxorubicin and CA125 Level Variability Analysis in Platinum-refractory/resistant Recurrent Ovarian Cancer
      TAKUMA OOYAMA, YUKO SHIMOJI, TADAHARU NAKASONE, YOSHIHISA ARAKAKI, YUSUKE TAIRA, TOMOKO NAKAMOTO, WATARU KUDAKA and YOICHI AOKI
      Anticancer Research June 2022, 42 (6) 3017-3022; DOI: https://doi.org/10.21873/anticanres.15786

  10. Arakaki, YOSHIHISA

    1. Effects of Pegylated Liposomal Doxorubicin and CA125 Level Variability Analysis in Platinum-refractory/resistant Recurrent Ovarian Cancer
      TAKUMA OOYAMA, YUKO SHIMOJI, TADAHARU NAKASONE, YOSHIHISA ARAKAKI, YUSUKE TAIRA, TOMOKO NAKAMOTO, WATARU KUDAKA and YOICHI AOKI
      Anticancer Research June 2022, 42 (6) 3017-3022; DOI: https://doi.org/10.21873/anticanres.15786
« Previous (Pages : 1 2 3 4 5 6 ... 48) Next »
Back to top

In this issue